Working together to reduce the global burden of kidney cancer
Kidney cancer is a global issue. Every year, 431,000 people worldwide will be diagnosed with kidney cancer.
Click here for shareable information, graphics and materials about kidney cancer for patient organisations worldwide.
World Kidney Cancer Day 2025 – 19 June
Save the date: The next World Kidney Cancer Day will be on Thursday 19th June 2025. It is celebrated around the world every year on the third Thursday of June by patients, carers, healthcare professionals and local organisations.
Show your kidneys some love is the theme for the 2025 campaign. Based on findings from the recent Global Patient Survey, we will be focusing on raising awareness of the importance of kidney health when affected by kidney cancer.
Summary of Kidney Cancer Highlights from ASCO 2025
This year’s American Society of Clinical Oncology (ASCO) Annual Meeting was held from 30 May to 3 June 2025, in Chicago, USA. The presentations are available to view on the ASCO website. Some affiliates of the International Kidney Cancer Coalition (IKCC) went to the meeting to keep up to date with the care and treatment of patients with kidney cancer. A brief “Take home messages” section is followed by more in-depth review of selected abstracts.
2025 Global Patient Survey Highlights Report – Now Online
The 2025 Global Patient Survey Highlights Report is now available online. The report offers a snapshot of the worldwide kidney cancer patient experience, examining the geographical differences and unmet patient needs related to kidney cancer diagnosis, knowledge, quality of life, shared decision-making, clinical trials and kidney function.
Learn more about IKCC’s biennial Global Patient Survey on Kidney Cancer, including the 2025 Highlights Report here:
Tweets from @IKCCorg
;
Merci @TELUS_Spark d’avoir illuminé en vert à l’occasion de la #JournéeMondialeDuCancerDuRein. Le centre est magnifique ! 💚 #cancerdurein
Thank you @TELUS_Spark for lighting up green for #WorldKidneyCancerDay! The centre looks stunning in green 💚 #kidneycancer
WOW!! That is impressive!! Thank you Telus Spark Science for ‘lighting up in green’ to support the Canadian #kidneycancer community on June 19 #WorldKidneyCancerDay and bringing awareness. 💚
@KidneyCancer_Ca
@CancerduRein
@IKCCorg
Dr. Hans Hammers is a pioneer in kidney cancer immunotherapy and serves on our Board of Directors. We're proud to spotlight his extraordinary contributions to science, and his commitment to pushing research forward for patients everywhere.
#RestoreTheResearch #AccereratingCures
Proud to be part of this pivotal trial and to have learned so much from Dr. Srinivasan and our patients. @theNCI @OSUCCC_James @OSU_Urology @KimrynRathmell @KidneyCancer @kidneycan @IKCCorg @KidneyCancer_Ca
📢 Big win for a rare kidney cancer subtype!
In HLRCC-associated papillary RCC, bevacizumab + erlotinib delivered a 72% response rate and median PFS of 21.1 months.
🧬 Germline FH-mutated pRCC finally gets a targeted shot.
#Oncology #RCC #HLRCC #KidneyCancer #PrecisionMedicine…
Did you know?
Kidney cancer is often found by accident.
Kidney cancer is the 14th most prevalent cancer worldwide.
About 59 per cent of kidney cancer cases occur in more developed countries.
Our Global Network
IKCC welcomes every organisation that has an interest in kidney cancer and who pledges to conform to our Code of Conduct. We extend an open invitation to become part of this international network.
Join our mailing list
In the newsletter we highlight news about kidney cancer diagnosis and treatment, and other relevant discussions.